Medical Equipment

Molecular Cytogenetics Market Growth Expected To Reach $5.12 Billion By 2030 At 10.6% CAGR

April 14, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Molecular Cytogenetics Market During 2026–2030?

The molecular cytogenetics market has seen rapid expansion in recent years. This market is expected to grow from $3.1 billion in 2025 to $3.42 billion in 2026, at a compound annual growth rate (CAGR) of 10.4%. The increase observed in the past period can be linked to a greater incidence of genetic disorders, the broadening scope of cancer diagnostic testing, the development of academic and clinical genetics research, the availability of advanced laboratory instruments, and a heightened demand for detecting chromosomal abnormalities.

The molecular cytogenetics market is anticipated to show significant expansion in the upcoming years. Its valuation is projected to achieve $5.13 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.6%. This expansion during the forecast period is driven by the increasing integration of personalized medicine techniques, heightened investments in genomic research, the broadening of precision oncology diagnostics, a rising demand for unified cytogenetic workflows, and continuous progress in imaging and molecular analysis technologies. Prominent trends for the forecast period encompass a greater adoption of FISH and CGH technologies, the growing utilization of genomic profiling in oncology, increased integration of automated cytogenetic platforms, the widening application of bioinformatics-driven data interpretation, and an amplified focus on high-throughput cytogenetic analysis.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/molecular-cytogenetics-global-market-report

What Primary Drivers Are Shaping The Molecular Cytogenetics Market?

The increasing occurrence of genetic disorders and various cancers is anticipated to fuel the expansion of the molecular cytogenetics market in the future. Cancer is characterized by the unrestrained proliferation of abnormal cells, which subsequently spread to adjacent or remote areas within the body. This growing prevalence of such conditions stems from inherited predispositions, environmental influences, and risks associated with aging, leading to a greater demand for patient diagnostic assessments. Molecular cytogenetics plays a crucial role in clinical decision-making by facilitating the precise identification of chromosomal irregularities, including absent, fractured, or reordered chromosomes, thereby aiding in the diagnosis of birth defects, inherited illnesses, and various forms of cancer. As an illustration, the National Blood Authority, an Australian blood management organization, reported in July 2025 that the number of individuals with hereditary haemophilia A (HMA) increased from 2,681 patients in 2022–2023 to 2,788 patients in 2023–2024. Consequently, the expanding occurrence of genetic conditions and cancer is a key factor propelling the growth of the molecular cytogenetics market.

What Are The Key Segment Divisions In The Molecular Cytogenetics Market Segment Structure?

The molecular cytogenetics market covered in this report is segmented –

1) By Product: Instruments, Kits And Reagents, Software, Services

2) By Technology: Comparative Genomic Hybridization, Fluorescence In Situ Hybridization, Karyotyping, Other Technologies

3) By Application: Genetic Disorders, Cancer, Personalized Medicines, Other Applications

4) By End-User: Clinical And Research Laboratories, Academic Research Institutes, Pharmaceutical, Biotechnology Companies, Other End-Users

Subsegments:

1) By Instruments: Fluorescence In Situ Hybridization (FISH) Systems, Microarray Platforms, Imaging Systems

2) By Kits And Reagents: DNA Extraction Kits, Hybridization Kits, Staining Kits

3) By Software: Data Analysis Software, Image Analysis Software, Bioinformatics Tools, Laboratory Information Management Systems (LIMS), Reporting Software

4) By Services: Custom Research Services, Technical Support Services, Consulting Services, Training Services, Quality Control Services

What Trends Are Affecting The Growth Of The Molecular Cytogenetics Market?

Major companies operating in the molecular cytogenetics market are actively developing novel products, such as the LUTHOR High-Definition Single Cell 3′ mRNA-Seq Kit, to satisfy increasing demand and capitalize on expanding market opportunities. This particular kit revolutionizes single-cell RNA sequencing through an RNA-amplification-based approach that can identify almost every single mRNA molecule present within a cell. For example, Lexogen GmbH, an Austria-based biotechnology company, introduced the LUTHOR High-Definition Single Cell 3′ mRNA-Seq Kit in November 2023. This advanced protocol establishes new standards in single-cell RNA sequencing, facilitating the detection of even a single gene copy inside a cell and successfully capturing 95% of expressed genes at a 1 million read depth. The exceptional sensitivity of LUTHOR HD is underpinned by its innovative THOR (T7 High-resolution Original RNA amplification) technology, which directly amplifies RNA from the original mRNA, thereby overcoming constraints related to low-copy transcripts.

Which Organizations Are Engaged In The Molecular Cytogenetics Market?

Major companies operating in the molecular cytogenetics market are Abbott Laboratories, Agilent Technologies Inc, Applied Spectral Imaging, CytoTest Inc, Danaher Corporation, Illumina Inc, PerkinElmer Inc, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Oxford Gene Technology Limited, Affymetrix Inc, F. Hoffmann-La Roche AG, Cytognomix Inc, Empire Genomics LLC, Genial Genetic Solutions Ltd., BioChain Institute Inc, BioGenex Laboratories Inc, Bio-Techne Corporation, Cytocell Ltd., Kreatech Diagnostics B.V., Leica Biosystems Nussloch GmbH, MetaSystems Group Holding GmbH, SciGene Corporation, SkylineDx B.V., Roche Diagnostics Corporation

Get The Full Molecular Cytogenetics Market Report:

https://www.thebusinessresearchcompany.com/report/molecular-cytogenetics-global-market-report

Which Region Accounts For The Largest Portion Of The Molecular Cytogenetics Market?

North America was the largest region in the molecular cytogenetics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global molecular cytogenetics market report during the forecast period. The regions covered in the molecular cytogenetics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Molecular Cytogenetics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/molecular-cytogenetics-global-market-report

Browse Through More Reports Similar to the Global Molecular Cytogenetics Market 2026, By The Business Research Company

Epigenetics Market Report 2026

https://www.thebusinessresearchcompany.com/report/epigenetics-global-market-report

Molecular Breeding Market Report 2026

https://www.thebusinessresearchcompany.com/report/molecular-breeding-global-market-report

Pharmacogenomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacogenomics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795